Live from the NIH registry
Studies recruiting near Albany right now
Top 25 of 197 recruiting studies, sorted by proximity — each links to its official registry page
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma
Low Grade Astrocytoma, Low Grade Glioma
Phase 3
Interventional 170 participants sought
Albany Medical Center — Albany, New York (2.4 mi)
· Sponsor: National Cancer Institute (NCI)
A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss
Childhood Medulloblastoma
Phase 3
Interventional 225 participants sought
Albany Medical Center — Albany, New York (2.4 mi)
· Sponsor: Children's Oncology Group
RENAISSANCE 2: SPN-817 Phase 2, Double-Blind, Placebo-Controlled Study in Adults With Focal Onset Seizures
Focal Onset Seizures
Phase 2
Interventional 216 participants sought
Albany Medical Center — Albany, New York (2.4 mi)
· Sponsor: Supernus Pharmaceuticals, Inc.
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
Type 2 Diabetes, Cortisol Excess
Phase 2
Interventional 1,500 participants sought
Albany Medical College — Albany, New York (2.4 mi)
· Sponsor: Sparrow Pharmaceuticals
ENdoluminal LIGHT ActivatED Treatment of Upper Tract Urothelial Cancer (ENLIGHTED) Study
Transitional Cell Cancer of Renal Pelvis and Ureter
Phase 3
Interventional 100 participants sought
Albany Medical College — Albany, New York (2.4 mi)
· Sponsor: Steba Biotech S.A.
A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes
Type 1 Diabetes Mellitus With Hypoglycemia
Phase 2
Interventional 186 participants sought
Albany Medical Center — Albany, New York (2.4 mi)
· Sponsor: Zucara Therapeutics Inc.
A Clinical Trial of Calderasib (MK-1084) and Durvalumab in People With Non-Small Cell Lung Cancer (MK-1084-015/KANDLELIT-015)
Non-small Cell Lung Cancer
Phase 3
Interventional 310 participants sought
New York Oncology Hematology P.C ( Site 9000) — Albany, New York (2.4 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.
Chronic Kidney Disease
Phase 3
Interventional 7,000 participants sought
Research Site — Albany, New York (2.4 mi)
· Sponsor: AstraZeneca
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis
Phase 3
Interventional 762 participants sought
89bio Clinical Study Site — Albany, New York (2.4 mi)
· Sponsor: 89bio, Inc.
A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
Prostate Cancer
Phase 3
Interventional 700 participants sought
Research Site — Albany, New York (2.4 mi)
· Sponsor: AstraZeneca
A Phase 2 Study of Budoprutug in Subjects With Primary Membranous Nephropathy
Primary Membranous Nephropathy
Phase 2
Interventional 45 participants sought
Climb Bio Investigative Site #101 — Clifton Park, New York (13.8 mi)
· Sponsor: Climb Bio, Inc.
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Atherosclerotic Cardiovascular Disease, Overweight
Phase 3
Interventional 12,800 participants sought
Saratoga Clinical Research, LLC — Saratoga Springs, New York (28.8 mi)
· Sponsor: Amgen
A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
Primary Myelofibrosis (PMF), Post-polycythemia Vera Myelofibrosis (PPV-MF)
Phase 3
Interventional 460 participants sought
New York Oncology Hematology P C — Albany, New York (2.4 mi)
· Sponsor: Novartis Pharmaceuticals
A Study to Investigate the Efficacy and Safety of Apraglutide Compared With Placebo in Adult Participants With Short Bowel Syndrome Associated With Intestinal Failure (SBS-IF)
Short Bowel Syndrome (SBS), SBS Associated With Intestinal Failure (SBS-IF)
Phase 3
Interventional 124 participants sought
Albany Medical Center — Albany, New York (2.4 mi)
· Sponsor: VectivBio AG
Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT
Newly Diagnosed Multiple Myeloma
Phase 3
Interventional 750 participants sought
Research Site — Albany, New York (2.4 mi)
· Sponsor: AstraZeneca
A Study About How Blood Cell Growth Patterns Relate to Heart Health After Treatment for Hodgkin Lymphoma
Cardiovascular Disorder, Classic Hodgkin Lymphoma
N/A
Observational 190 participants sought
Albany Medical Center — Albany, New York (2.4 mi)
· Sponsor: Children's Oncology Group
Optimal Pulse Width Used in Transcutaneous Electrical Nerve Stimulation for Treating Nocturnal Enuresis in Children
Nocturnal Enuresis, Bedwetting
N/A
Interventional 70 participants sought
Albany Medical College — Albany, New York (2.4 mi)
· Sponsor: Albany Medical College
Global Paradise System US Post Approval Study
Hypertension, Cardiovascular Diseases
N/A
Observational 1,000 participants sought
Albany Medical Center — Albany, New York (2.4 mi)
· Sponsor: ReCor Medical, Inc.
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants
Hypothyroidism
Phase 2, Phase 3
Interventional 2,800 participants sought
Albany Medical College- Endocrinology Washington Extension /ID# 256794 — Albany, New York (2.4 mi)
· Sponsor: AbbVie
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
Heart Failure
Phase 3
Interventional 11,300 participants sought
Research Site — Albany, New York (2.4 mi)
· Sponsor: AstraZeneca
A Study to Learn More About the Health of Persons With Down Syndrome After Treatment for Acute Leukemia
B Acute Lymphoblastic Leukemia Associated With Down Syndrome, Down Syndrome
N/A
Observational 330 participants sought
Albany Medical Center — Albany, New York (2.4 mi)
· Sponsor: Children's Oncology Group
Treating Pulmonary Embolism With Laguna Thrombectomy System (TRUST)
Pulmonary Embolism
N/A
Interventional 107 participants sought
Albany Medical Center — Albany, New York (2.4 mi)
· Sponsor: Innova Vascular, Inc.
A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
High Grade Osteosarcoma, Localized Osteosarcoma
Phase 2, Phase 3
Interventional 1,122 participants sought
Albany Medical Center — Albany, New York (2.4 mi)
· Sponsor: National Cancer Institute (NCI)
The Society for Obstetric Anesthesia and Perinatology Research Network General Anesthesia Registry
Cesarean Delivery, General Anesthesia
N/A
Observational 5,000 participants sought
Albany Medical Center — Albany, New York (2.4 mi)
· Sponsor: Yale University
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Albany Medical Center — Albany, New York (2.4 mi)
· Sponsor: National Cancer Institute (NCI)